NGM Biopharmaceuticals, Inc. is a privately held drug discovery company committed to identifying transformational medicines that dramatically improve human health. Based on emerging human clinical and genetic observations, the Company has devised several innovative experimental approaches to discover new therapies for the treatment of metabolic and cardiovascular diseases. Our current focus is on the gastrointestinal endocrine system, with an aim to identify novel factors implicated in the pathogenesis of type 2 diabetes and the apparent resolution of this grievous disease in patients who have undergone gastric bypass surgery.
Current Team (10)Update
Founder, President and Chief Scientific Officer
Vice President, Clinical Research
Executive Director, Research Operations
Vice President CMC and Technical Operations
Senior Director, Protein Sciences
Vice President, Research
Funding Rounds (4) - $144.9MUpdate
Board Members and Advisors (2)Update
Rho Ventures is a private equity firm that invests in high growth companies across multiple...
Tichenor Ventures is a financial organization. Nothing is publicly known about the organization...
Topspin is the successor fund to the Long Island Venture Fund, a successful venture capital fund...
Prospect Venture Partners is a Palo Alto, California based venture capital firm with over $1B of...
Venture capital Firm
630 Gateway Blvd
South San Francisco, CA 94080-7014